Organon & Co.
$13.52 -$0.04 (-0.29%) 1D After hours
Organon & Co.
Key Metrics
The Story So Far
LAST 6 MONTHS PRIMARY SOURCES ONLY-
Jul 23
A material event was filed (Form 8-K).
8-K - Organon & Co. (0001821825) (Filer)
RECEIPT: SEC FORM 8-K, TIMESTAMPED -
Jul 17
A material event was filed (Form 8-K).
8-K - Organon & Co. (0001821825) (Filer)
RECEIPT: SEC FORM 8-K, TIMESTAMPED -
Jul 16
Money rotated out of high-beta cohorts market-wide.
High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.
RECEIPT: ROTATION GAUGE, LIVE -
Apr 24
The stock moved +30.9% in a single session.
Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.
RECEIPT: DAILY BAR, Apr 24 -
Apr 10
The stock moved +27.8% in a single session.
Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.
RECEIPT: DAILY BAR, Apr 10 -
Mar 30
From its Jan 29 high, the share price fell 34%.
Peak close $8.60 on Jan 29; trough close $5.70 on Mar 30. The drawdown is the fact — the chapters around it are the context.
RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -34%
The story updates itself as events post · The wolf reports; you decide
Snapshot
About Organon & Co.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day.
Wolf Grade COMING SOON
The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.